Delivery Order SPE2DR25D3101-SPE2DR26F5V62
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,266.71 to AmerisourceBergen Drug Corp for the supply of Naloxone HCl 4 mg nasal spray. This contract, which was competitively awarded with no set-aside designation, has a firm fixed price structure and an ultimate completion date of August 18, 2025. The product will be delivered to a location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,503.20 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray on November 24, 2025, with completion scheduled for November 25, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $3,834.55 firm fixed price delivery order to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray (2-dose units) on December 10, 2025, with an ultimate completion date of December 11, 2025. This non-competitive delivery order will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,255.47 to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray (2-count units) on November 7, 2025, with completion targeted for November 10, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,519.77 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray (2-count units) on August 18, 2025, with completion targeted for August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply framework. Performance will be executed from the company's Conshohocken, Pennsylvania location,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,384.94 to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray (2-count units) on December 18, 2025, with completion targeted for December 19, 2025. This is a firm fixed-price contract with no set-aside designation, issued under competitive procedures. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract executed...
- The Defense Logistics Agency awarded a delivery order valued at $3,708.70 to AmerisourceBergen Drug Corp for the supply of Naloxone HCl 4 mg nasal spray (2-count units). This competitive delivery order, issued on December 27, 2025, with an ultimate completion date of December 29, 2025, represents a firm fixed-price transaction with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $9,093.31 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray (2-pack units) on December 8, 2025, with completion scheduled for December 9, 2025. This competitively awarded, firm fixed-price delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply support to federal military...
- The Defense Logistics Agency awarded a $4,622.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Naloxone HCL 4 mg nasal spray on November 28, 2025, with an ultimate completion date of December 1, 2025. This award is a non-set-aside contract and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $2,641.54 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray on December 8, 2025, with completion scheduled for December 9, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitively awarded delivery order for pharmaceutical supplies to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- SPE2DR25D3101Indefinite Delivery Contract
- SPE2DR25D3101-SPE2DR26F5V62Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,129.92 to AmerisourceBergen Drug Corp for the supply of Naloxone HCl 4 mg nasal spray on January 2, 2026, with an ultimate completion date of January 5, 2026. This firm fixed-price contract, issued without set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order is executed under AmerisourceBergen's DLA Troop Support Medical prime indefinite delivery contract (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor, AmerisourceBergen supplies a broad range of medications and medical supplies to support Defense Health Agency operations and other federal healthcare systems. The naloxone supply supports emergency medical response capabilities within military and federal healthcare networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 1/1/26 |